Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Omalizumab for asthma.

× No keyword cloud information.

52 in total

Review 1. Management of asthma in children.

Authors: J Townshend; S Hails; M McKean
Journal: BMJ Date: 2007-08-04

Review 2. Pharmacotherapy of asthma.

Authors: Martin M Zdanowicz
Journal: Am J Pharm Educ Date: 2007-10-15 Impact factor: 2.047

3. Differences in effects of omalizumab on late-phase responses to allergen challenge in the skin and nose at the time of basophil hyporesponsiveness.

Authors: Miya O Paterniti; Linda M Breslin; Jean-Paul Courneya; Patricia M Sterba; Robert G Hamilton; Donald W MacGlashan; Sarbjit S Saini
Journal: J Invest Dermatol Date: 2013-12-23 Impact factor: 8.551

4. The effect of omalizumab on ventilation and perfusion in adults with allergic asthma.

Authors: Daniel A Kelmenson; Vanessa J Kelly; Tilo Winkler; Mamary T Kone; Guido Musch; Marcos F Vidal Melo; Jose G Venegas; R Scott Harris
Journal: Am J Nucl Med Mol Imaging Date: 2013-07-10

Review 5. Narrative review: the role of Th2 immune pathway modulation in the treatment of severe asthma and its phenotypes.

Authors: Stewart J Levine; Sally E Wenzel
Journal: Ann Intern Med Date: 2010-02-16 Impact factor: 25.391

Review 6. Severe asthma: an expanding and mounting clinical challenge.

Authors: Matthew C Bell; William W Busse
Journal: J Allergy Clin Immunol Pract Date: 2013-02-26

Review 7. Resolution of allergic asthma.

Authors: Susetta Finotto
Journal: Semin Immunopathol Date: 2019-11-08 Impact factor: 9.623

Review 8. The use of biologics for immune modulation in allergic disease.

Authors: Willem van de Veen; Mübeccel Akdis
Journal: J Clin Invest Date: 2019-03-18 Impact factor: 14.808

9. Ablation of tumor progression locus 2 promotes a type 2 Th cell response in Ovalbumin-immunized mice.

Authors: Wendy T Watford; Chun-Chi Wang; Christos Tsatsanis; Lisa A Mielke; Aristides G Eliopoulos; Constantine Daskalakis; Nicolas Charles; Sandra Odom; Juan Rivera; John O'Shea; Philip N Tsichlis
Journal: J Immunol Date: 2009-12-02 Impact factor: 5.422

10. Effects of omalizumab on basophil and mast cell responses using an intranasal cat allergen challenge.

Authors: John A Eckman; Patricia M Sterba; Denise Kelly; Val Alexander; Mark C Liu; Bruce S Bochner; Donald W Macglashan; Sarbjit S Saini
Journal: J Allergy Clin Immunol Date: 2009-12-04 Impact factor: 10.793